Using Long-acting Injectable Cabotegravir and Rilpivirine to Improve Adherence with HIV-1 Treatment

Using Long-acting Injectable Cabotegravir and Rilpivirine to Improve Adherence with HIV-1 Treatment

Bibliographic Details
Main Author: Dr. Chadane Thompson
Format: Article
Language:English
Published: Trinidad and Tobago Medical Association (T&TMA) 2022-04-01
Series:Caribbean Medical Journal
Online Access:https://www.caribbeanmedicaljournal.org/2022/04/17/using-long-acting-injectable-cabotegravir-and-rilpivirine-to-improve-adherence-with-hiv-1-treatment/

Internet

https://www.caribbeanmedicaljournal.org/2022/04/17/using-long-acting-injectable-cabotegravir-and-rilpivirine-to-improve-adherence-with-hiv-1-treatment/

Similar Items